Paasa Logo
Intensity Therapeutics, Inc. logo
INTSNASDAQMarket closedOpens 9:30am ET

Intensity Therapeutics, Inc.

$3.89Last updated
-$0.21 (5.12%)Past day
Timezone

Intensity Therapeutics, Inc. (NASDAQ: INTS) is trading at $3.89, about ₹374 at today's USD/INR rate, as of 24 Sep 2026, 4:00 PM ET, down 5.12% today. Indian residents can buy Intensity Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$4.20
Previous close:$4.10
Volume:10.57K

Today's low

$3.89

Today's high

$4.20

52 week low

$3.51

52 week high

$43.50

INTS opened at $4.20, closed previously at $4.10, and has traded between $3.51 and $43.50 over the past 52 weeks.

About

Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers. The company's primary experimental compound, INT230-6, is presently undergoing Phase 2 clinical trials. This investigational drug targets a range of difficult-to-treat solid tumors, including those affecting the pancreas, colon, bile duct, as well as squamous cell, sarcoma, breast, and liver cancers. Intensity Therapeutics has formed strategic collaborations with major pharmaceutical companies and research institutions: A partnership with Merck Sharpe & Dohme Corp. focuses on evaluating INT230-6 in conjunction with Keytruda for advanced pancreatic, colon, squamous cell, and bile duct malignancies. Another collaboration with Bristol-Myers Squibb Company is dedicated to studying INT230-6 combined with Yervoy in patients suffering from advanced liver, breast, and sarcoma cancers. Furthermore, the company is working with the Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research on a randomized controlled Phase II neoadjuvant study of INT230-6 for women diagnosed with early-stage breast cancer. Established in 2012, Intensity Therapeutics maintains its corporate headquarters in Westport, Connecticut.

Country
US
CEO
Lewis H. Bender
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
16
Sector
Healthcare
IPO date
30/06/2023

Key statistics

Avg. volume

36.08K

Market cap

$10.51M

P/E Ratio

-0.81

Price-to-sales ratio

0.00

Enterprise value

$1.08M

Free cash flow yield

-85.16%

Debt-to-equity ratio

0.01

Return on equity

-116.61%

ROIC

-123.35%

Beta

3.03

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$8.56

Free cash flow

-$9.23M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$11.61M

Revenue growth

—

Similar securities

This is not an investment recommendation

How to buy Intensity Therapeutics from India

Indian residents can buy Intensity Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Intensity Therapeutics and place an order

    Find Intensity Therapeutics by name or by its ticker, INTS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Intensity Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Intensity Therapeutics position in USD and INR. Intensity Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Intensity Therapeutics from India

Trading and taxes when buying Intensity Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneIntensity Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Intensity Therapeutics stock?

Yes. Intensity Therapeutics (INTS) has been listed on NASDAQ since 2023, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Intensity Therapeutics share cost in rupees?

One Intensity Therapeutics share is $3.89 — about ₹374 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Intensity Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Intensity Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Intensity Therapeutics?

Yes. One Intensity Therapeutics share is $3.89, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Intensity Therapeutics.

How are gains on Intensity Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Intensity Therapeutics price. Paasa issues a capital-gains statement for your return.

Does Intensity Therapeutics pay a dividend?

No. Intensity Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Intensity Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Intensity Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Intensity Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Intensity Therapeutics holding, its cost and its closing value.

How do I sell Intensity Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.